Sichenzia Ross Friedman Ference LLP Advises AV Therapeutics, Inc. on $1.26 million PIPE Offering
NEW YORK, April 30, 2014 (GLOBE NEWSWIRE) — New York based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented AV Therapeutics, Inc. (OTCQB:AVTH) on a $1.26 million private placement of units consisting of common stock and warrants at a unit price of $0.20. AV Therapeutics, Inc. is engaged in the business of developing cancer therapeutics and immunotherapeutic vaccines that can be used alone or in combination with prevalent treatment modalities such as chemotherapy and radiation to treat active disease and to prevent metastases and recurrence. The Sichenzia Ross Friedman Ference LLP team was led by partner Darrin M. Ocasio.
Visit SRF's LinkedIn page
Latest posts by Sichenzia Ross Ference LLP (see all)
- Attorneys Selected for Inclusion on 2019 Super Lawyers Lists - October 16, 2019
- Sichenzia Ross Ference LLP to Join Client Relmada Therapeutics, Inc. at Nasdaq Opening Bell Ringing - October 15, 2019
- Sichenzia Ross Ference LLP Congratulates Relmada Therapeutics, Inc., on NASDAQ Uplisting - October 10, 2019